Astellas Gene Therapies Competitors and Similar CompaniesClear all

Astellas Gene Therapies's competitors and similar companies include Keros Therapeutics, Denali Therapeutics, Futura Genetics and Curate Biosciences.
Astellas Gene Therapies
Astellas Gene Therapies
Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
Keros Therapeutics
Keros Therapeutics
Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
Denali Therapeutics
Denali Therapeutics
Denali Therapeutics is a clinical stage biopharmaceutical company.
Futura Genetics
Futura Genetics
Futura Genetics specializes in lifestyle and healthcare genetic testing.
Curate Biosciences
Curate Biosciences
Curate Biosciences (formerly known as GPB Scientific) is a company involved in the processing of cells for gene and cell therapies.
Founding Date
Founding Date
2013
Founding Date
2015
Founding Date
2015
Founding Date
2014
Founding Date
2002
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
San Francisco, US HQ
Locations
Lexington, US HQ
South Wharf, AU
Locations
South San Francisco, US HQ
Zürich, CH
London, GB
Locations
Tel Aviv-Yafo, IL HQ
Coquitlam, CA
Locations
Carlsbad, US HQ
Richmond, US
Employees
Employees
3981% decrease
Employees
1365% increase
Employees
4454% increase
Employees
5
Employees
4
Valuation ($)
Valuation ($)
N/A
Valuation ($)
2.3 b
Valuation ($)
4 b
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$151k (FY, 2023)
Revenue (est.)
$330.5m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($128.8m) (FY, 2018)
Net income
($153m) (FY, 2023)
Net income
($145.2m) (FY, 2023)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 180m
Total funding raised
$ 90m
Total funding raised
$ 424.4m
Total funding raised
N/A
Total funding raised
$ 31.5m
For sources of this data, please see the company profile

View Company Profiles

Keros Therapeutics
HQ
Lexington, US
Employees
136↑ 5% increase

Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.

View company
Denali Therapeutics
HQ
South San Francisco, US
Employees
445↑ 4% increase

Denali Therapeutics is a clinical stage biopharmaceutical company.

View company
Futura Genetics
HQ
Tel Aviv-Yafo, IL
Employees
5

Futura Genetics specializes in lifestyle and healthcare genetic testing.

View company
Curate Biosciences
HQ
Carlsbad, US
Employees
4

Curate Biosciences (formerly known as GPB Scientific) is a company involved in the processing of cells for gene and cell therapies.

View company